Bioidentical Hormones: Evidence, Myths, and What to Ask Your GP

If you've searched for menopause treatment options online, you've almost certainly encountered the term "bioidentical hormones." It's marketed as a more natural, safer, and personalised alternative to conventional hormone therapy. But the reality is more complicated than the marketing suggests.

Understanding what "bioidentical" actually means, the difference between MHRA-approved and compounded products, and what the evidence does and doesn't support is essential for making informed decisions about your care.

What "bioidentical" actually means

The term "bioidentical" refers to hormones that are chemically identical in molecular structure to the hormones your body produces. Bioidentical estradiol is the same molecule as the estradiol made by your ovaries. Bioidentical progesterone is the same molecule as the progesterone your ovaries produce.

This is a molecular description, not a source description. All bioidentical hormones used in commercial products, whether MHRA-approved or compounded, are synthesised in laboratories. Most are derived from plant precursors (typically wild yam or soy), but they are then chemically processed into the final hormone molecule. The plant source does not make them "natural" in any meaningful pharmacological sense.

MHRA-approved vs. compounded: the critical distinction

This is where the conversation gets important. There are two pathways for obtaining bioidentical hormones, and they are not equivalent:

MHRA-approved bioidentical hormones

Several MHRA-approved products contain bioidentical hormones. These include estradiol patches (Evorel, Estradot, and generics), estradiol gels (Oestrogel, Sandrena), micronised progesterone capsules (Utrogestan), and vaginal estradiol preparations. Many of these are available on NHS prescription.

These products have undergone rigorous clinical trials to establish safety, efficacy, and consistent dosing. They are manufactured under strict MHRA oversight with standardised quality control. Every patch, capsule, or gel delivers a consistent, tested dose.

Compounded bioidentical hormones

Compounded hormones are custom-mixed by compounding pharmacies, often based on a prescriber's specification for a particular combination or dose. While compounding serves an important role in medicine (for patients who need doses or formulations not commercially available), compounded hormone products are not MHRA-approved.

This means they have not undergone clinical trials, their dosing consistency may vary between batches, and they are not subject to the same manufacturing standards as MHRA-approved products.

Why compounded hormones have surged

The popularity of compounded bioidentical hormones has grown significantly, driven by several factors:

• Fear of conventional HRT. In the wake of the WHI scare, compounded "natural" hormones were marketed as a safer alternative, even though there was no evidence supporting this claim.
• Personalisation appeal. The idea of a custom-tailored hormone formulation is intuitively appealing, even though MHRA-approved products are available in a wide range of doses and formulations.
• NHS access difficulties. Long waiting times for NHS menopause specialist appointments and inconsistent GP knowledge of HRT have pushed some women toward private compounding clinics.
• Direct-to-consumer marketing. Private clinics and online pharmacies have aggressively marketed compounded hormones, often with claims that go beyond what the evidence supports.

What the evidence shows

The scientific evidence on compounded bioidentical hormones is limited, primarily because these products have not been through the clinical trial process. This doesn't mean they're necessarily unsafe, but it does mean we know less about them.

What we do know:

• The bioidentical molecules themselves (estradiol, progesterone) have a strong evidence base when used in MHRA-approved formulations. The molecule is the same whether it comes from a pharmaceutical manufacturer or a compounding pharmacy.
• Dosing consistency is a legitimate concern with compounded products. Regulatory investigations have found that a significant percentage of tested compounded hormone preparations did not contain the labelled dose. Some had too much, some too little.
• Compounded products sometimes include hormones like estriol or DHEA that have limited evidence for safety and efficacy in menopause treatment.
• Salivary hormone testing, often promoted alongside compounded hormones as a way to "personalise" dosing, has not been validated as a reliable method for adjusting hormone therapy doses. Blood levels are preferred when monitoring is needed.

Medical society positions

Every major medical organisation that has weighed in on this topic has reached a similar conclusion:

• The British Menopause Society (BMS) recommends regulated, MHRA-approved hormone therapy over compounded products and cautions against using custom compounded hormones when an approved alternative exists.
• NICE (National Institute for Health and Care Excellence) guidelines on menopause recommend body-identical (bioidentical) hormones such as estradiol and micronised progesterone, specifically in their regulated, approved forms.
• The Endocrine Society recommends regulated hormone therapy over compounded products and cautions against using custom compounded hormones when an approved alternative exists.
• The Royal College of Obstetricians and Gynaecologists has expressed concern about the marketing of compounded hormones and recommends regulated products as the first-line option.

Red flags to watch for

When evaluating a clinician or pharmacy offering bioidentical hormones, be cautious of the following:

None of these automatically mean you're receiving bad care, but each warrants a closer look and a second opinion if you're unsure.

Questions to ask your GP or consultant

Whether you're considering MHRA-approved or compounded bioidentical hormones, these questions can help guide a productive conversation:

1. Is there an MHRA-approved product that would work for me? Start here. If your needs can be met by a regulated product, that's typically the safest option. Many are available on NHS prescription.
2. What is the specific rationale for compounding? There should be a clear clinical reason, such as a specific dose not available commercially or an allergy to an ingredient in commercial products.
3. What hormones are in this formulation, and what is the evidence for each? If the formulation includes hormones beyond estradiol and progesterone (like estriol, DHEA, or testosterone), ask what evidence supports their use for your symptoms.
4. How will we monitor whether this is working? Symptom response is the primary measure. If your clinician relies solely on lab values (especially salivary testing), ask about the evidence supporting that approach.
5. What are the risks specific to my health history? A thoughtful clinician will discuss your individual risk factors, not just reassure you that bioidentical hormones are "safe."
6. Are you a BMS-accredited menopause specialist? Specialised training matters for hormone therapy prescribing.

The bottom line

The word "bioidentical" describes a molecular structure, not a safety profile. Both MHRA-approved and compounded products can contain bioidentical hormones. The difference lies in the evidence base, manufacturing standards, and regulatory oversight.

For most women, MHRA-approved bioidentical hormone products offer the strongest combination of proven efficacy, dosing consistency, and safety data. Compounded hormones have a role in specific clinical situations, but the marketing around them has often outpaced the evidence.

The most important decision is not which pharmacy fills your prescription. It's having a knowledgeable clinician who can help you navigate the options based on your individual health profile, symptoms, and preferences.